AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Big prospects for nanotech

25/06/2002Source:Red Herring. Steven Milunovich 

Nanotechnology is increasingly gaining favour with venture capitalists, although VCs remain cautious that this optimism does not turn into a bubble such as that experienced by the dot-com industry. Nanotech could possibly become a prime target for venture capital funding this year, says Steven Milunovich of Red Herring.

The mapping of the human genome has given rise to a number of new research tools. Biotechnology is poised to undergo enormous growth in the next few years and nanotech will play a big part in this rise.

Click here to view article

Copyright © Red Herring November 2001

This article was given with kind permission of Red Herring, for more information, please contact www.redherring.com

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter